Splanchnic Vein Thrombosis in Candidates for Liver Transplantation: Usefulness of Screening and Anticoagulation

Overview

Journal Gut

Specialty Gastroenterology

Date 2005 Apr 16

PMID 15831918

Citations 140

Authors

C Francoz

J Belghiti

V Vilgrain

D Sommacale

V Paradis

B Condat

M H Denninger

A Sauvanet

D Valla

F Durand

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Splanchnic vein thrombosis is a significant source of complications in candidates for liver transplantation. The aims of this study were: (a) to determine the prevalence of and risk factors for splanchnic vein thrombosis in cirrhotic patients awaiting transplantation and (b) to assess the usefulness of anticoagulation.

Methods: A total of 251 cirrhotic patients listed for transplantation were analysed. All underwent systematic screening for thrombosis with Doppler ultrasonography. During the second period of the study, all patients with thrombosis received anticoagulation up to transplantation while during the first period none had received anticoagulation.

Results: The incidence of splanchnic vein thrombosis at evaluation was 8.4%. Seventeen additional patients (7.4%) developed de novo thrombosis after evaluation. Independent risk factors for thrombosis were low platelet count (77.4 (36.3) v 111.6 (69.2) 10(9)/l; p = 0.001), a past history of variceal bleeding (47.4% v 29.1%; p = 0.003), and a prolonged interval from listing to transplantation (8.5 (6.8) v 4.8 (4.4) months; p = 0.002). The proportion of partial or complete recanalisation was significantly higher in those who received (8/19) than in those who did not receive (0/10, p = 0.002) anticoagulation. Survival was significantly lower in those who had complete portal vein thrombosis at the time of surgery (p = 0.04).

Conclusion: These results support a systematic screening for splanchnic vein thrombosis in patients awaiting transplantation. They suggest that in these patients, anticoagulation is safe and has a significant impact on recanalisation as well as prevention of extension of thrombosis.

Citing Articles

Comparable hemostatic capacity of blood taken from the portal vein compared with systemic blood in patients with cirrhosis.

Blasi A, Calvo A, Mellado R, Torrente M, Turon F, Garcia-Pagan J Res Pract Thromb Haemost. 2024; 8(7):102583.

PMID: 39552771 PMC: 11567948. DOI: 10.1016/j.rpth.2024.102583.

The Molecular Mechanisms of Portal Vein Thrombosis in Hepatocellular Carcinoma.

Galasso L, Cerrito L, Termite F, Mignini I, Esposto G, Borriello R Cancers (Basel). 2024; 16(19).

PMID: 39409869 PMC: 11482560. DOI: 10.3390/cancers16193247.

Hepatic vein thrombosis and PVT: A personal view on the contemporary development of ideas.

Valla D Clin Liver Dis (Hoboken). 2024; 23(1):e0246.

PMID: 38988821 PMC: 11236412. DOI: 10.1097/CLD.0000000000000246.

Management of extensive portal vein thrombosis via thrombolysis and thrombectomy without underlying liver disease: A case report.

Gul M, Umer W, Nawaz A, Elhissi M, Zahid M Clin Case Rep. 2024; 12(7):e8920.

PMID: 38952464 PMC: 11215528. DOI: 10.1002/ccr3.8920.

Portal Vein Thrombosis: State-of-the-Art Review.

Boccatonda A, Gentilini S, Zanata E, Simion C, Serra C, Simioni P J Clin Med. 2024; 13(5).

PMID: 38592411 PMC: 10932352. DOI: 10.3390/jcm13051517.

References

Marn C, Francis I . CT of portal venous occlusion. AJR Am J Roentgenol. 1992; 159(4):717-26. DOI: 10.2214/ajr.159.4.1326882. View

Nonami T, Yokoyama I, Iwatsuki S, Starzl T . The incidence of portal vein thrombosis at liver transplantation. Hepatology. 1992; 16(5):1195-8. PMC: 2989675. View

Davidson B, Gibson M, Dick R, Burroughs A, Rolles K . Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation. 1994; 57(8):1174-7. DOI: 10.1097/00007890-199404270-00006. View

Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F . Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334(11):693-9. DOI: 10.1056/NEJM199603143341104. View

Karatzas T, Demirbas A, Tsaroucha A, Phipps J, Nery J, Webb M . Management of portal vein thrombosis in liver transplantation. Transplant Proc. 1997; 29(7):2866-7. DOI: 10.1016/s0041-1345(97)00711-2. View

Taourel P, Blanc P, Dauzat M, Chabre M, Pradel J, Gallix B . Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure. Hepatology. 1998; 28(4):932-6. DOI: 10.1002/hep.510280406. View

Robles R, Parrilla P, Hernandez Q, Bueno F, Ramirez P, Lopez J . Liver transplantation in cirrhotic patients with thrombosis of the portal vein. Transplant Proc. 1999; 31(6):2415. DOI: 10.1016/s0041-1345(99)00409-1. View

Amitrano L, Brancaccio V, Guardascione M, Margaglione M, Iannaccone L, DAndrea G . Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology. 2000; 31(2):345-8. DOI: 10.1002/hep.510310213. View

Denninger M, Chait Y, Casadevall N, Hillaire S, Guillin M, Bezeaud A . Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology. 2000; 31(3):587-91. DOI: 10.1002/hep.510310307. View

10.

Yerdel M, Gunson B, Mirza D, Karayalcin K, Olliff S, Buckels J . Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000; 69(9):1873-81. DOI: 10.1097/00007890-200005150-00023. View

11.

Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D . Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000; 32(3):466-70. DOI: 10.1053/jhep.2000.16597. View

12.

Condat B, Pessione F, Hillaire S, Denninger M, Guillin M, Poliquin M . Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001; 120(2):490-7. DOI: 10.1053/gast.2001.21209. View

13.

Manzanet G, Sanjuan F, Orbis P, Lopez R, Moya A, Juan M . Liver transplantation in patients with portal vein thrombosis. Liver Transpl. 2001; 7(2):125-31. DOI: 10.1053/jlts.2001.21295. View

14.

Olausson M, Norrby J, Mjornstedt L, Liden H, Friman S . Liver transplantation using cavoportal hemitransposition- a life-saving procedure in the presence of extensive portal vein thrombosis. Transplant Proc. 2001; 33(1-2):1327-8. DOI: 10.1016/s0041-1345(00)02494-5. View

15.

Miller V, Berland L . Pulsed Doppler duplex sonography and CT of portal vein thrombosis. AJR Am J Roentgenol. 1985; 145(1):73-6. DOI: 10.2214/ajr.145.1.73. View

16.

Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N . Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology. 1985; 89(2):279-86. DOI: 10.1016/0016-5085(85)90327-0. View

17.

Lerut J, Tzakis A, Bron K, Gordon R, Iwatsuki S, Esquivel C . Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg. 1987; 205(4):404-14. PMC: 1492747. DOI: 10.1097/00000658-198704000-00011. View

18.

Kawasaki T, Moriyasu F, Nishida O, Ban N, Nakamura T, Tamada T . Analysis of hepatofugal flow in portal venous system using ultrasonic Doppler duplex system. Am J Gastroenterol. 1989; 84(8):937-41. View

19.

Gaiani S, Bolondi L, Li Bassi S, Zironi G, Siringo S, Barbara L . Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology. 1991; 100(1):160-7. DOI: 10.1016/0016-5085(91)90596-d. View

20.

Stieber A, Zetti G, Todo S, Tzakis A, Fung J, MARINO I . The spectrum of portal vein thrombosis in liver transplantation. Ann Surg. 1991; 213(3):199-206. PMC: 1358327. DOI: 10.1097/00000658-199103000-00003. View